Apricus Biosciences' Reverse Merger Round

Apricus Biosciences raised a round of funding on July 30, 2018. Investors include Seelos Therapeutics.

Apricus Biosciences is a pharmaceutical company that has leveraged the flexibility of clinically-validated NexACT drug delivery technology to enable multi-route administration of new and improved comp…

Articles about Apricus Biosciences' Reverse Merger Round: